UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations

Cancer research (Chicago, Ill.), 2015-12, Vol.75 (24), p.5341-5354

2015

Volltextzugriff (PDF)

ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

Cancer research (Chicago, Ill.), 2021-04, Vol.81 (7), p.1704-1718

2021

Volltextzugriff (PDF)

Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13), p.3502-3512

2017

Volltextzugriff (PDF)

Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer

Cancer research (Chicago, Ill.), 2015-03, Vol.75 (6), p.1091-1101

2015

Volltextzugriff (PDF)

Abstract PS15-18: Clinical utility of genomic testing for early stage breast cancer patients treated with APBI brachytherapy

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS15-18-PS15-18

2021

Volltextzugriff (PDF)

Abstract 1306: Density-based mutation clustering in 3D space

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1306-1306

2018

Volltextzugriff (PDF)

Abstract NG14: Proteome instability is an immunogenic therapeutic vulnerability in mismatch repair deficient cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.NG14-NG14

2020

Volltextzugriff (PDF)

Abstract 552: Circulating tumor DNA predicts disease recurrence in ovarian cancer patients

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.552-552

2021

Volltextzugriff (PDF)

Abstract 1747: Oncolytic Vesicular Stomatitis Virus expressing a species relevant interferon-beta is safe and provides a survival benefit when added as neoadjuvant to the standard of care for dogs with naturally occurring bone cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1747-1747

2021

Volltextzugriff (PDF)

Abstract 671: Development of an exosomal biomarker signature to detect minimal residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.671-671

2021

Volltextzugriff (PDF)

Abstract 3399: Comparative genomic analyses of osteosarcoma etiology reveal a chromosomal structural rationale for the increased incidence of osteosarcoma in dogs

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3399-3399

2018

Volltextzugriff (PDF)

Abstract 2357: Utilizing biological and protein structure-guided features to improve driver mutation discovery

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2357-2357

2018

Volltextzugriff (PDF)

Abstract PR03: Nongenomic BAP1 aberrancy drives highly aggressive cutaneous melanoma phenotype

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19_Supplement), p.PR03-PR03

2020

Volltextzugriff (PDF)

Abstract PR06: Functional prioritization of rare gene aberration drivers of cancer

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22_Supplement_1), p.PR06-PR06

2015

Volltextzugriff (PDF)

Abstract 1099: High-throughput engineering and functional annotation of cancer fusion genes

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1099-1099

2015

Volltextzugriff (PDF)

Abstract 4275: Identifying cancer driver mutations in clinical sequencing data

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4275-4275

2014

Volltextzugriff (PDF)

Abstract B106: Personalized functional screens for gene drivers of pancreatic cancer

Cancer research (Chicago, Ill.), 2015-07, Vol.75 (13_Supplement), p.B106-B106

2015

Volltextzugriff (PDF)

Abstract CT008: Phase I study of the alpha specific PI3-Kinase inhibitor BYL719 and the poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib in recurrent ovarian and breast cancer: Analysis of the dose escalation and ovarian cancer expansion cohort

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT008-CT008

2017

Volltextzugriff (PDF)

Abstract P4-06-04: Triple negative breast cancer patient-derived xenografts: Molecular characteristics and sensitivity to emerging therapies

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-06-04

2017

Volltextzugriff (PDF)

Abstract IA11: Functionalization the cancer genome

Cancer research (Chicago, Ill.), 2012-07, Vol.72 (13_Supplement), p.IA11-IA11

2012

Volltextzugriff (PDF)

Abstract LB-003: Androgen-regulated proteome reveals a therapeutically relevant androgen receptor coactivator target in prostate cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-003-LB-003

2016

Volltextzugriff (PDF)

Abstract LB-176: The human androgen receptor regulates DNA damage response (DDR) in prostate cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-176-LB-176

2016

Volltextzugriff (PDF)

Abstract 4276: T200: a high depth targeted exome sequencing platform to identify actionable alterations in FFPE solid tumor samples

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4276-4276

2014

Volltextzugriff (PDF)

Abstract LB-228: Resistance to BRAF inhibition in BRAF V600E colorectal cancer is associated with PI3K/AKT activation and hypermethylation

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.LB-228-LB-228

2011

Volltextzugriff (PDF)

Abstract 3141: Hyperglycemia modulates the Wnt /b-catenin signaling pathway in breast cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3141-3141

2010

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(4)
Oncology
(4)
Science & Technology
(4)
Animals
(3)
Humans
(3)
Mice
(3)
Cell Line, Tumor
(2)
Female
(2)
Mice, Nude
(2)
Breast Neoplasms - Genetics
(1)
C-Met Protein
(1)
Cancer
(1)
Cell Transformation, Neoplastic - Genetics
(1)
Class I Phosphatidylinositol 3-Kinases
(1)
Construction
(1)
Disease Models, Animal
(1)
Dna Mutational Analysis - Methods
(1)
Fusion Protein
(1)
Fusion Proteins, Bcr-Abl - Genetics
(1)
Genes
(1)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations

ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer

Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer

Abstract PS15-18: Clinical utility of genomic testing for early stage breast cancer patients treated with APBI brachytherapy

Abstract 1306: Density-based mutation clustering in 3D space

Abstract NG14: Proteome instability is an immunogenic therapeutic vulnerability in mismatch repair deficient cancer

Abstract 552: Circulating tumor DNA predicts disease recurrence in ovarian cancer patients

Abstract 1747: Oncolytic Vesicular Stomatitis Virus expressing a species relevant interferon-beta is safe and provides a survival benefit when added as neoadjuvant to the standard of care for dogs with naturally occurring bone cancer

Abstract 671: Development of an exosomal biomarker signature to detect minimal residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning

Abstract 3399: Comparative genomic analyses of osteosarcoma etiology reveal a chromosomal structural rationale for the increased incidence of osteosarcoma in dogs

Abstract 2357: Utilizing biological and protein structure-guided features to improve driver mutation discovery

Abstract PR03: Nongenomic BAP1 aberrancy drives highly aggressive cutaneous melanoma phenotype

Abstract PR06: Functional prioritization of rare gene aberration drivers of cancer

Abstract 1099: High-throughput engineering and functional annotation of cancer fusion genes

Abstract 4275: Identifying cancer driver mutations in clinical sequencing data

Abstract B106: Personalized functional screens for gene drivers of pancreatic cancer

Abstract CT008: Phase I study of the alpha specific PI3-Kinase inhibitor BYL719 and the poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib in recurrent ovarian and breast cancer: Analysis of the dose escalation and ovarian cancer expansion cohort

Abstract P4-06-04: Triple negative breast cancer patient-derived xenografts: Molecular characteristics and sensitivity to emerging therapies

Abstract IA11: Functionalization the cancer genome

Abstract LB-003: Androgen-regulated proteome reveals a therapeutically relevant androgen receptor coactivator target in prostate cancer

Abstract LB-176: The human androgen receptor regulates DNA damage response (DDR) in prostate cancer

Abstract 4276: T200: a high depth targeted exome sequencing platform to identify actionable alterations in FFPE solid tumor samples

Abstract LB-228: Resistance to BRAF inhibition in BRAF V600E colorectal cancer is associated with PI3K/AKT activation and hypermethylation

Abstract 3141: Hyperglycemia modulates the Wnt /b-catenin signaling pathway in breast cancer

Aktive Filter

Suchergebnisse filtern